Related Experiment Videos
Chemotherapy for metastatic breast cancer--when is enough enough?
European Journal of Cancer (Oxford, England : 1990)
|February 21, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study.
Brain, behavior, & immunity - health·2021
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo.
Pulmonary pharmacology & therapeutics·2019
Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study.
British journal of cancer·2017
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.
European journal of cancer (Oxford, England : 1990)·2026
Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026
Integrating patient preferences into clinical trial outcomes for older adults with cancer: A perspective from the EORTC Older Adult Council and Quality of Life Group.
European journal of cancer (Oxford, England : 1990)·2026
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy.
European journal of cancer (Oxford, England : 1990)·2026
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Human vaccines & immunotherapeutics·2026
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.
Hematology (Amsterdam, Netherlands)·2026
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.
Asia-Pacific journal of clinical oncology·2026